Line 4: |
Line 4: |
| {{Under Construction}} | | {{Under Construction}} |
| | | |
− | <blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023-11-30. The original page can be found at [[HAEM4:Primary Cutaneous Anaplastic Large Cell Lymphoma]]. | + | <blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023-12-04. The original page can be found at [[HAEM4:Primary Cutaneous Anaplastic Large Cell Lymphoma]]. |
| }}</blockquote> | | }}</blockquote> |
| ==Primary Author(s)*== | | ==Primary Author(s)*== |
Line 355: |
Line 355: |
| ==Links== | | ==Links== |
| | | |
− | *[[Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders]] | + | *[[HAEM4:Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders]] |
− | *[[Lymphomatoid Papulosis]] | + | *[[HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis]] |
− | *[[Anaplastic Large Cell Lymphoma, ALK-Negative]] | + | *[[HAEM5:ALK-negative anaplastic large cell lymphoma]] |
− | *[[Anaplastic Large Cell Lymphoma, ALK-Positive]] | + | *[[HAEM5:ALK-positive anaplastic large cell lymphoma]] |
− | *[[Mycosis Fungoides]] | + | *[[HAEM5:Mycosis fungoides]] |
| | | |
| ==References== | | ==References== |